<ruby id="zqerw"><i id="zqerw"><strike id="zqerw"></strike></i></ruby>
  • <small id="zqerw"><del id="zqerw"></del></small>

    產品資料

    骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer

    產品名稱: 骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer
    產品型號: C02-120-10D-100ug
    產品展商: peprotech
    產品文檔: 無相關文檔

    簡單介紹

    骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer系列產品主要適用于試驗室或生化科研相關試驗,CANSPEC品質提供的骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer性能**,中文名稱為骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer。


    骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer  的詳細介紹

    產品名稱:骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer

    產品規格:

    C02-120-10D-100ug骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer100ug¥12,250
    C02-120-10D-1mg骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer1mg¥54,600
    C02-120-10D-20ug骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer20ug¥1,960
    C02-120-10D-500ug骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer500ug¥32,760
    C02-120-10D-5ug骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer5ug¥680

    單        位:瓶

    關 鍵 字:骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer


    CANSPEC品質提供的骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer性能**,英文名稱骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer,簡稱為骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer,中文名稱為骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer。

    產品骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer以其優良的品質滿足您不同實驗的多種需求。并保證每批        的質量和骨形態生成蛋白-4(BMP-4)拮抗劑Noggin二聚體|Human NOGGIN-Dimer品質優良。

    English Information

    Synonyms :

    none.

    Description :

    Noggin belongs to a group of diffusible proteins which bind to ligands of the TGF-β family and regulate their activity by inhibiting their access to signaling receptors. The interplay between TGF-β ligands and their natural antagonists has major biological significance during development processes, in which cellular response can vary considerably depending upon the local concentration of the signaling molecule. Noggin was originally identified as a BMP-4 antagonist whose action is critical for proper formation of the head and other dorsal structures. Consequently, Noggin has been shown to modulate the activities of other BMPs including BMP-2,-7,-13, and -14. Targeted deletion of Noggin in mice results in prenatal death and recessive phenotype displaying a severely malformed skeletal system. Conversely, transgenic mice over-expressing Noggin in mature osteoblasts display impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis. Recombinant human Noggin is a 46.2 kDa disulfide-linked homodimer (120-10D) consisting of two 206 amino acid polypeptide chains.

    Catalog #:

    120-10D

    Source :

    E.coli

    Stability :

    The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted Noggin is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles.

    Purity :

    Greater than 95% by SDS-PAGE gel and HPLC analyses.

    Endotoxin Level :

    Endotoxin level is less than 0.1 ng per μg (1EU/μg).

    Biological Activity :

    Determined by its ability to inhibit 5.0 ng/ml of BMP-4 induced alkaline phosphatase production by ATDC chondrogenic cells. The expected The ED50 for this effect is 0.01-0.02 μg/ml of Noggin.

    AA Sequence :

    MQHYLHIRPA PSDNLPLVDL IEHPDPIFDP KEKDLNETLL RSLLGGHYDP GFMATSPPED RPGGGGGAAG GAEDLAELDQ LLRQRPSGAM PSEIKGLEFS EGLAQGKKQR LSKKLRRKLQ MWLWSQTFCP VLYAWNDLGS RFWPRYVKVG SCFSKRSCSV PEGMVCKPSK SVHLTVLRWR CQRRGGQRCG WIPIQYPIIS ECKCSC

    PubMed Link :

    Noggin

    Country of Origin :

    USA

     

    滬公網安備 31011402005168號

    欧美精品专区高清在线爱美_香蕉久久一区二区不卡无毒影院_亚洲精品国产福利在线观看_久久AV无码精品人妻系列果冻
    <ruby id="zqerw"><i id="zqerw"><strike id="zqerw"></strike></i></ruby>
  • <small id="zqerw"><del id="zqerw"></del></small>